Syneos Health Inc. (SYNH)
NASDAQ: SYNH
· Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Sep 27, 2023, 10:00 PM
Syneos Health Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.37B | 1.36B | 1.36B | 1.34B | 1.36B | 1.34B | 1.37B | 1.35B | 1.28B | 1.21B |
Cost of Revenue | 1.07B | 1.09B | 1.04B | 1.02B | 1.03B | 1.04B | 1.02B | 1.03B | 992.58M | 945.25M |
Gross Profit | 294.72M | 268.25M | 318.16M | 318.44M | 325.84M | 291.82M | 348.62M | 316.34M | 290.03M | 263.5M |
Operating Income | 42.22M | 35.78M | 94.86M | 117.84M | 116.6M | 73.9M | 131.22M | 113.36M | 83.68M | 61.02M |
Interest Income | 1.71M | 528K | 1.27M | 303K | 36K | 3K | n/a | n/a | n/a | 71K |
Pretax Income | 661K | -75.16M | 40.7M | 116.69M | 103.68M | 53.49M | 116.7M | 100.41M | 51.04M | 47.01M |
Net Income | 793K | -72.15M | 55.53M | 87.05M | 77.74M | 46.18M | 75.96M | 78.24M | 41.91M | 38.72M |
Selling & General & Admin | 182.52M | 161.52M | 137.69M | 130.35M | 139.04M | 140.17M | 149.26M | 139.52M | 144.67M | 137.31M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -841K | 61.59M | 62.24M | 61.51M | 61.22M | -2.81M | 2.78M | 2.92M | -1.3M | 1.48M |
Operating Expenses | 241.85M | 223.1M | 199.94M | 191.87M | 200.26M | 202.37M | 212.98M | 195.78M | 202.38M | 195.25M |
Interest Expense | 37.88M | 26.26M | 25.13M | 22.13M | 18.1M | 15.77M | 16.49M | 16.77M | 22.62M | 23.33M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.31B | 1.31B | 1.24B | 1.21B | 1.24B | 1.25B | 1.24B | 1.23B | 1.19B | 1.14B |
Income Tax Expense | -132K | -3.01M | -14.82M | 29.64M | 25.94M | 7.32M | 40.74M | 22.17M | 9.13M | 8.29M |
Shares Outstanding (Basic) | 103.68M | 103.33M | 102.91M | 102.73M | 102.6M | 103.67M | 103.72M | 103.56M | 103.94M | 104.27M |
Shares Outstanding (Diluted) | 104.34M | 103.33M | 103.22M | 103.21M | 103.07M | 104.41M | 105M | 104.78M | 105.02M | 105.46M |
EPS (Basic) | 0.01 | -0.7 | 0.54 | 0.85 | 0.75 | 0.44 | 0.73 | 0.76 | 0.40 | 0.37 |
EPS (Diluted) | 0.01 | -0.7 | 0.54 | 0.84 | 0.75 | 0.44 | 0.72 | 0.75 | 0.40 | 0.37 |
EBITDA | 113.06M | 97.37M | 152.2M | 186.33M | 187.29M | 148.85M | 202.14M | 179.74M | 144.06M | 127.73M |
EBIT | 38.54M | 26.42M | 65.84M | 138.82M | 121.79M | 69.26M | 133.19M | 117.18M | 73.66M | 70.34M |
Depreciation & Amortization | 59.33M | 61.59M | 57.35M | 68.49M | 70.69M | 62.2M | 63.72M | 56.25M | 57.71M | 57.94M |